Furthermore, blood-based stages proved valuable in detecting clinical diagnostic and PET-based stages, as well as associating with the longitudinal progression of the disease, including Aβ- and tau-PET accumulation, atrophy and cognitive decline. The gene discussed is MAPT; the disease is Atrophy.